Matthew M. Hufford

2.4k total citations · 1 hit paper
24 papers, 1.6k citations indexed

About

Matthew M. Hufford is a scholar working on Immunology, Epidemiology and Rheumatology. According to data from OpenAlex, Matthew M. Hufford has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Matthew M. Hufford's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (7 papers) and Spondyloarthritis Studies and Treatments (6 papers). Matthew M. Hufford is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (7 papers) and Spondyloarthritis Studies and Treatments (6 papers). Matthew M. Hufford collaborates with scholars based in United States, United Kingdom and France. Matthew M. Hufford's co-authors include Thomas J. Braciale, Mark H. Kaplan, Matthew R. Olson, Taeg S. Kim, Inmaculada de la Torre, Peter C. Taylor, Robert Gottlieb, Andrew C. Adams, Kevin Winthrop and Jie Sun and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Nature reviews. Immunology.

In The Last Decade

Matthew M. Hufford

24 papers receiving 1.6k citations

Hit Papers

Neutralizing monoclonal antibodies for treatment of COVID-19 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew M. Hufford United States 16 871 502 334 281 162 24 1.6k
Martin Larsen France 24 1.1k 1.3× 273 0.5× 566 1.7× 340 1.2× 269 1.7× 56 2.0k
Mikkel‐Ole Skjoedt Denmark 26 1.6k 1.8× 384 0.8× 265 0.8× 337 1.2× 50 0.3× 64 2.2k
Matthias Tenbusch Germany 28 886 1.0× 422 0.8× 452 1.4× 491 1.7× 115 0.7× 91 2.1k
Eliseo Albert Spain 20 512 0.6× 804 1.6× 363 1.1× 256 0.9× 242 1.5× 103 1.9k
Marisa Benagiano Italy 26 1.1k 1.3× 462 0.9× 475 1.4× 346 1.2× 298 1.8× 59 2.3k
Alexis Vogelzang Germany 19 1.5k 1.7× 671 1.3× 381 1.1× 389 1.4× 210 1.3× 25 2.2k
Xuejun Chen United States 22 588 0.7× 260 0.5× 316 0.9× 408 1.5× 194 1.2× 61 1.8k
Matthias Hoffmann Germany 24 1.2k 1.4× 322 0.6× 361 1.1× 279 1.0× 257 1.6× 82 2.4k
Gianpiero D’Offizi Italy 27 657 0.8× 757 1.5× 758 2.3× 300 1.1× 191 1.2× 127 2.4k
Sherri L. Surman United States 31 984 1.1× 541 1.1× 829 2.5× 471 1.7× 227 1.4× 88 2.2k

Countries citing papers authored by Matthew M. Hufford

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Hufford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Hufford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Hufford more than expected).

Fields of papers citing papers by Matthew M. Hufford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Hufford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Hufford. The network helps show where Matthew M. Hufford may publish in the future.

Co-authorship network of co-authors of Matthew M. Hufford

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Hufford. A scholar is included among the top collaborators of Matthew M. Hufford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Hufford. Matthew M. Hufford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Dipak, Martin Böhm, Himanshu P. Upadhyaya, et al.. (2024). Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19. Infectious Diseases and Therapy. 13(10). 2123–2134. 2 indexed citations
2.
Ulrich, Benjamin J., Michelle Chu, Byunghee Koh, et al.. (2023). ERG Functionally Overlaps with Other Ets Proteins in Promoting TH9 Cell Expression of Il9 during Allergic Lung Inflammation. The Journal of Immunology. 210(5). 537–546. 6 indexed citations
3.
Coates, Laura C., Sreekumar Pillai, Hasan Tahir, et al.. (2021). Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study. Arthritis & Rheumatology. 73(9). 1663–1672. 16 indexed citations
4.
Taylor, Peter C., Andrew C. Adams, Matthew M. Hufford, et al.. (2021). Neutralizing monoclonal antibodies for treatment of COVID-19. Nature reviews. Immunology. 21(6). 382–393. 453 indexed citations breakdown →
5.
Combe, Bernard, Tsen‐Fang Tsai, J. Eugene Huffstutter, et al.. (2021). Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies. Arthritis Research & Therapy. 23(1). 41–41. 13 indexed citations
6.
Tillett, William, Joseph F. Merola, Diamant Thaçi, et al.. (2020). Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey. Rheumatology and Therapy. 7(3). 617–637. 29 indexed citations
7.
Kavanaugh, Arthur, Alice B. Gottlieb, Akimichi Morita, et al.. (2019). The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Annals of the Rheumatic Diseases. 78(9). 1215–1219. 37 indexed citations
8.
Coates, Laura C., Alexis Ogdie, Prashanth Sunkureddi, et al.. (2019). FRI0426 IXEKIZUMAB MAKES REMISSION AND LOW DISEASE ACTIVITY POSSIBLE IN PATIENTS WITH PSORIATIC ARTHRITIS: TWO-YEAR RESULTS IN TNF INADEQUATE RESPONDERS OR BIOLOGIC-NAïVE PATIENTS. Annals of the Rheumatic Diseases. 78. 902–903. 1 indexed citations
9.
Koh, Byunghee, Matthew M. Hufford, Xin Sun, & Mark H. Kaplan. (2017). Etv5 Regulates IL-10 Production in Th Cells. The Journal of Immunology. 198(5). 2165–2171. 14 indexed citations
10.
Olson, Matthew R., et al.. (2016). STAT3 Impairs STAT5 Activation in the Development of IL-9–Secreting T Cells. The Journal of Immunology. 196(8). 3297–3304. 31 indexed citations
11.
Koh, Byunghee, Matthew M. Hufford, Duy Pham, et al.. (2016). The ETS Family Transcription Factors Etv5 and PU.1 Function in Parallel To Promote Th9 Cell Development. The Journal of Immunology. 197(6). 2465–2472. 38 indexed citations
12.
Kaplan, Mark H., Matthew M. Hufford, & Matthew R. Olson. (2015). The development and in vivo function of T helper 9 cells. PMC. 1 indexed citations
13.
Kaplan, Mark H., Matthew M. Hufford, & Matthew R. Olson. (2015). The development and in vivo function of T helper 9 cells. Nature reviews. Immunology. 15(5). 295–307. 272 indexed citations
14.
Moser, Emily K., Matthew M. Hufford, & Thomas J. Braciale. (2014). Late Engagement of CD86 after Influenza Virus Clearance Promotes Recovery in a FoxP3+ Regulatory T Cell Dependent Manner. PLoS Pathogens. 10(8). e1004315–e1004315. 46 indexed citations
15.
Hufford, Matthew M., Taeg S. Kim, Jie Sun, & Thomas J. Braciale. (2014). The Effector T Cell Response to Influenza Infection. Current topics in microbiology and immunology. 386. 423–455. 17 indexed citations
16.
Yoo, Jae‐Kwang, Taeg S. Kim, Matthew M. Hufford, & Thomas J. Braciale. (2013). Viral infection of the lung: Host response and sequelae. Journal of Allergy and Clinical Immunology. 132(6). 1263–1276. 117 indexed citations
17.
Górski, S, Matthew M. Hufford, & Thomas J. Braciale. (2012). Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract. Current Opinion in Virology. 2(3). 233–241. 26 indexed citations
18.
Hufford, Matthew M., Graham Richardson, Haixia Zhou, et al.. (2012). Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells. PLoS ONE. 7(10). e46581–e46581. 86 indexed citations
19.
Kim, Taeg S., Matthew M. Hufford, Jie Sun, Yang‐Xin Fu, & Thomas J. Braciale. (2010). Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. The Journal of Experimental Medicine. 207(6). 1161–1172. 147 indexed citations
20.
Hufford, Matthew M., Taeg S. Kim, Jie Sun, & Thomas J. Braciale. (2010). Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. The Journal of Experimental Medicine. 208(1). 167–180. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026